Drug Patents owned by Sanofi
1. Drug name - RENVELA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7985418 | SANOFI | Aliphatic amine polymer salts for tableting |
Oct, 2025
(3 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 800MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.